contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


vistin-pharma-asa-invitation-to-q2-2024-conference-call

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Vistin Pharma

Oslo, Norway, 16 August 2024 Vistin Pharma ASA will release its second quarter and YTD 2024 results on Friday 23rd of August 2024. Vistin Pharma will host a conference call for all shareholders...

Oslo, Norway, 16 August 2024 Vistin Pharma ASA will release its second quarter and YTD 2024 results on Friday 23rd of August 2024. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day;&nbsp;Friday&nbsp;23rd of August at 08:30 CET. There will be a Q&amp;A session following the management discussion. The conference call will be held in English. The second quarter conference call will be available via web and audio through the following access points: Webcast: <a href="https://www.globenewswire.com/Tracker?data=6ZCamEYNDbH675fG-7hEa-Gh5dDVBTBxg6N9Qtp1uZpGq5rDn3qnu9jjLxQF8u9Uc2twIqPxSjVB44prAvC--1DJeTeWYDRZPFp5cIvFmlGjR8Wor51BtL293v8rILUUeIhaA-E17l_wPmQCXYwsKb2BrUPDt9d6txNqLuVbEo0=">https://edge.media-server.com/mmc/p/v93s3oau</a> Telephone conference (online registration): <a href="https://www.globenewswire.com/Tracker?data=6ZCamEYNDbH675fG-7hEa2PXwEVYJQBjFy7LhfePLwIJSuWRCHO80r9PRYMFzt8DY0RA_UU_IxUCemqMFEyf6ETdNTxwJNtIr9QSB-ACgnLano16VewZPAMbfv3tnYWgORWYwlrURmH2Yxy8f6KGn1LpQfppZy2jz-ro9nALn9LEE2SymCELB5pR84VRoZI64o2Kq6f6x7oGF5AQxdbaPXYWxMuktSA6FIFoZC7N0nU=">https://register.vevent.com/register/BIe6d25489e7ce45c18e8661e4d04d1d9a</a> ***** For further information, please contact: Alexander Karlsen CFO +47 97053621 alexander.karlsen@vistin.com About Vistin Pharma | www.vistin.com Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø. &nbsp; <img src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMDk2OTc0NyM0MDE4OTAyMTkjMjAxODc1NA=="> <img src="https://ml-eu.globenewswire.com/media/OGFkZTY0NGMtYzU3Yi00ZDRhLTljOTctMzM0ZjFkMjM3YjAxLTEwMzAzMjc=/tiny/Vistin-Pharma-ASA.png">

Vistin Pharma ASA: Invitation to Q2 2024 conference call

Federal Reserven korkopäätös: Kiire loppui tähän

Lääkekehityssijoittaminen: Arvonluonti yrityskaupoilla ja lisensointisopimuksilla

EKP:n korkopäätös: Keskuspankki ilman rajoitteita

Euroalueen ostopäälliköt: Onks sen jälkeen vielä mäki?

Laskuviikko takana Euroopassa, EKP:n viesti sai lopulta velkakirjakorot nousuun

Pysy ajantasalla Inderesin uutiskirjeillä